FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children
WHIPPANY, N.J.--(BUSINESS WIRE) August 7, 2020 -- Bayer announced today that the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news
More News: Chagas Disease | Children | Drugs & Pharmacology | Food and Drug Administration (FDA) | Pediatrics | USA Health